PubMed · 1995 · 80 citations · 27 references
MedicineNephrologyPathologyAutoimmunityImmunopathologyRenal PathologyAutoimmune DiseasesGlomerular DiseasesImmune-mediated Renal DiseaseRenal DiseaseRenal ImmunopathologyRenal InflammationAnti-neutrophil Cytoplasmic AntibodiesAnti-neutrophil Cytoplasmic Antibody TestingAnti-proteinase 3 AntibodiesMedian AgePauci-immune Glomerular InjuryRenal Involvement In VasculitisRenal VasculitisSystemic Vasculitis
During a seven-year period (1986-1992) 719 adults (age > 16 years) underwent diagnostic renal biopsy in Stockholm (adult population 1.2 million). Seventy-one (10%) new cases of pauci-immune necrotizing and crescentic glomerulonephritis (NCGN) with or without systemic vasculitis were found: 39 females and 32 males (median age 67, range 20-84 years). The mean yearly incidence for the whole period was 0.8/100,000 population. The yearly incidence doubled from 0.6 before to 1.2/100,000 population after 1990. The incidence was highest among those > 65 years of age. Age-corrected incidences for this age group increased from 1.4 before to 3.9/100,000 after 1990. Anti-neutrophil cytoplasmic antibodies (ANCAs) tested in 60, showed antibodies against proteinase 3 (PR3) in 29 patients, against myeloperoxidase (MPO) in 26 and none in five patients. Mortality was highest in the early stages of the disease. From a total of 11 patients, 7 (15%) died within 2.5 months of diagnosis. Forty-six out of all 71 patients with NCGN belonged to the catchment area of our clinic and were studied in more detail. Twenty-six had microscopic polyangiitis (ANCAs were analyzed in 24, of these 16 had anti-MPO, 6 anti-PR3, 2 had none), 13 had Wegener's granulomatosis (ANCAs were analyzed in all, of these 12 had anti-PR3, 1 anti-MPO) and seven had disease limited to the kidneys (ANCAs were analyzed in 6, 5 had anti-MPO, one was negative). At the time of diagnosis, 16 patients had s-creatinine < 300 mumol/l while 14 patients were dialysis-dependent (seven only temporarily). All patients received immunosuppressive therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
27
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Thomas J. Wang, Martin G. Larson, Daniel Levy et al. · New England Journal of Medicine · 2004 · 1.5K citations · Full text
Medicine, Cardiology, Physiology +11
Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage
Elmar Berendes, Michael Walter, Paul Cullen et al. · The Lancet · 1997 · 617 citations
Medicine, Neurology, Neurosurgery +14
Daniel G. Krauser, Donald M. Lloyd‐Jones, Claudia U. Chae et al. · American Heart Journal · 2005 · 255 citations